Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
236.5 GBX | -0.42% |
|
+0.76% | +4.54% |
05-09 | Spire Healthcare touts strong trading, backs outlook | AN |
05-09 | Spire Healthcare Reiterates FY24 Guidance | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company does not generate enough profits, which is an alarming weak point.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.54% | 1.22B | B- | ||
-32.87% | 13.37B | B+ | ||
+4.15% | 11.75B | B+ | ||
-3.60% | 11.57B | B | ||
+7.59% | 10.85B | B+ | ||
+26.83% | 8.55B | B | ||
-11.44% | 7.24B | A- | ||
+7.14% | 6.84B | B- | ||
+8.77% | 6.5B | D | ||
0.00% | 4.4B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SPI Stock
- Ratings Spire Healthcare Group plc